Using machine learning to understand Alzheimer's disease risk and differences among patients

Assessing Alzheimer disease risk and heterogeneity using multimodal machine learning approaches

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10898931

This study is looking to use smart computer technology to learn more about Alzheimer's disease by examining various types of information, including genetics and health details, to help us understand the disease better and find new ways to treat it, especially for people who are currently healthy.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10898931 on NIH RePORTER

What this research studies

This research aims to develop advanced machine learning models to better understand Alzheimer's disease (AD) by analyzing a wide range of data, including genetic and phenotypic information. The project will explore the different types of AD and assess risk factors in cognitively healthy individuals over time. By leveraging large-scale data from collaborative initiatives, the research seeks to identify patterns and interactions that could lead to improved understanding and potential future treatments for AD.

Who could benefit from this research

Good fit: Ideal candidates for this research include cognitively healthy older adults and individuals with varying stages of Alzheimer's disease.

Not a fit: Patients with advanced Alzheimer's disease who are already experiencing significant cognitive decline may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better identification of individuals at risk for Alzheimer's disease and tailored interventions.

How similar studies have performed: Previous research using machine learning approaches in Alzheimer's disease has shown promise, indicating that this methodology could yield valuable insights.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease biological markerAlzheimer's disease risk
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.